Summary Global Markets Direct’s, Age Related Macular Degeneration - Pipeline Review,H2 2012, provides an overview of the indication’s therapeutic pipeline. Thisreport provides information on the therapeutic development for Age RelatedMacular Degeneration, complete with latest updates, and special features onlate-stage and discontinued projects. It also reviews key players involved in thetherapeutic development for Age Related Macular Degeneration. Age RelatedMacular Degeneration - Pipeline Review, Half Year is built using data andinformation sourced from Global Markets Direct’s proprietary databases,Company/University websites, SEC filings, investor presentations and featuredpress releases from company/university sites and industry-specific third partysources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.
Scope- A snapshot of the global therapeutic scenario for Age Related MacularDegeneration.- A review of the Age Related Macular Degeneration products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Age Related Macular Degeneration.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.
Table of Contents :List of Tables 8List of Figures 11Introduction 12Global Markets Direct Report Coverage 12Age Related Macular Degeneration Overview 13Therapeutics Development 14An Overview of Pipeline Products for Age Related Macular Degeneration 14Age Related Macular Degeneration Therapeutics under Development byCompanies 16Age Related Macular Degeneration Therapeutics under Investigation byUniversities/Institutes 24Late Stage Products 27Comparative Analysis 27Mid Clinical Stage Products 28Comparative Analysis 28Early Clinical Stage Products 29Comparative Analysis 29Discovery and Pre-Clinical Stage Products 30Comparative Analysis 30………………
Please follow link if you want More RelatedReports :Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1
For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: email@example.com ,firstname.lastname@example.orgURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore